Healthcare provider profile · identity verified

Daniel E Munzing, MD

Family Practice · WHITEFISH, MT · NPI 1700844966

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	450	114
Levothyroxine Sodium	Levothyroxine Sodium	310	70
Lisinopril	Lisinopril	298	76
Hydrochlorothiazide	Hydrochlorothiazide	280	70
Amlodipine Besylate	Amlodipine Besylate	279	73
Losartan Potassium	Losartan Potassium	247	60
Omeprazole	Omeprazole	227	54
Gabapentin	Gabapentin	201	42
Tamsulosin Hcl	Tamsulosin Hcl	200	47
Potassium Chloride	Potassium Chloride	198	42
Metoprolol Succinate	Metoprolol Succinate	192	41
Furosemide	Furosemide	174	35
Metformin Hcl	Metformin Hcl	167	39
Escitalopram Oxalate	Escitalopram Oxalate	157	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	153	31
Zolpidem Tartrate	Zolpidem Tartrate	139	33
Allopurinol	Allopurinol	137	30
Trazodone Hcl	Trazodone Hcl	118	25
Simvastatin	Simvastatin	98	26
Albuterol Sulfate Hfa	Albuterol Sulfate	97	38
Eliquis	Apixaban	88	18
Pantoprazole Sodium	Pantoprazole Sodium	88	22
Meloxicam	Meloxicam	87	33
Duloxetine Hcl	Duloxetine Hcl	83	14
Metoprolol Tartrate	Metoprolol Tartrate	81	21
Rosuvastatin Calcium	Rosuvastatin Calcium	78	23
Quetiapine Fumarate	Quetiapine Fumarate	74	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	15
Tramadol Hcl	Tramadol Hcl	70	15
Prednisone	Prednisone	68	45
Triamcinolone Acetonide	Triamcinolone Acetonide	67	28
Lorazepam	Lorazepam	66	19
Finasteride	Finasteride	58	17
Alprazolam	Alprazolam	50	12
Donepezil Hcl	Donepezil Hcl	50	14
Carvedilol	Carvedilol	48	suppressed
Acyclovir	Acyclovir	47	19
Clopidogrel	Clopidogrel Bisulfate	46	suppressed
Jardiance	Empagliflozin	41	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Atenolol	Atenolol	33	suppressed
Azithromycin	Azithromycin	33	31
Montelukast Sodium	Montelukast Sodium	33	suppressed
Ozempic	Semaglutide	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	suppressed
Ondansetron Odt	Ondansetron	32	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Sertraline Hcl	Sertraline Hcl	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Estradiol	Estradiol	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Glipizide Er	Glipizide	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Benazepril Hcl	Benazepril Hcl	17	suppressed
Cephalexin	Cephalexin	17	13
Diazepam	Diazepam	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Risperidone	Risperidone	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Ampyra	Dalfampridine	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Colchicine	Colchicine	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Entacapone	Entacapone	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error